WeVote

Bill

Bill

HB 1122

Mandatory Coverage Hormone Replacement Therapy

2026 Regular Session

Colorado bill requiring health insurers to cover hormone replacement therapy, affecting healthcare access and insurance costs for patients and employers.

House Committee on Health & Human Services Postpone Indefinitely
0
WeVote Research Nonpartisan
Bill Summary · HB 1122

Legislative bill overview

HB 1122 would require health insurance plans in Colorado to provide mandatory coverage for hormone replacement therapy (HRT). The bill has recently been introduced in the House and referred to the Health & Human Services Committee for review and debate.

Why is this important

This bill directly affects healthcare access and costs for Coloradans who use HRT, whether for menopausal symptom management or gender-affirming care. Insurance mandates influence both patient affordability and insurer expenses, making this a significant policy question about healthcare coverage obligations.

Potential points of contention

  • Cost implications: Insurers and employers may argue mandatory coverage increases premium costs for all policyholders, while advocates counter that HRT is medically necessary and preventive care
  • Scope of HRT definition: Disagreement likely exists over which specific hormone therapies qualify (bioidentical vs. synthetic, dosages, duration limits), and whether coverage should differ by medical indication
  • Religious and ideological concerns: Some may object to mandatory coverage of gender-affirming hormone therapy on philosophical grounds, while others view this as necessary healthcare without legitimate grounds for exclusion

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.